Novel classes of viral and fungal inhibitors are disclosed. These compounds are useful in treating, preventing, and/or ameliorating viral infections such as, for example, Hepatitis C Virus, West Nile Virus, Dengue Virus, and Japanese Encephalitis Virus, and fungal infections such as, for example, candidiasis.
US8513295B2
申请人:——
公开号:US8513295B2
公开(公告)日:2013-08-20
[EN] VIRAL AND FUNGAL INHIBITORS<br/>[FR] INHIBITEURS VIRAUX ET FONGIQUES
申请人:UNIV GEORGETOWN
公开号:WO2010039534A2
公开(公告)日:2010-04-08
Novel classes of viral and fungal inhibitors are disclosed. These compounds are useful in treating, preventing, and/or ameliorating viral infections such as, for example, Hepatitis C Virus, West Nile Virus, Dengue Virus, and Japanese Encephalitis Virus, and fungal infections such as, for example, candidiasis.
Design, Synthesis, and In Vitro Evaluation of Potential West Nile Virus Protease Inhibitors Based on the 1-Oxo-1,2,3,4-tetrahydroisoquinoline and 1-Oxo-1,2-dihydroisoquinoline Scaffolds
作者:Dengfeng Dou、Prasanth Viwanathan、Yi Li、Guijia He、Kevin R. Alliston、Gerald H. Lushington、Joshua D. Brown-Clay、R. Padmanabhan、William C. Groutas
DOI:10.1021/cc100091h
日期:2010.11.8
The 1-oxo-1, 2, 3, 4-tetrahydroisoquinoline and 1-Oxo-1, 2-dihydroisoquinoline scaffolds were utilized in the design and solution phase synthesis of focused libraries of compounds for screening against WestNileVirus (WNV) protease. Exploratory studies have led to the identification of a WNV proteaseinhibitor (a 1-oxo-1, 2-dihydroisoquinoline-based derivative, 12j) which could potentially serve as